Since breast cancer cells in patients that express any NR2F1 did not consistently demonstrate the phenotype of dormancy, we investigated the association of NR2F1 expression and cancer cell mutation rates, as well as the cell fractions that constitute the TME of the NR2F1 high expression breast cancer. This evidence concerns the gene NR2F1 and breast cancer.